title: Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA. Electronic address: nirav.shah@uphs.upenn.edu.
authors.forename: Nirav N
authors.initials: NN
authors.lastname: Shah
authors.affiliation: Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
authors.forename: Neil
authors.initials: N
authors.lastname: Harrison
authors.affiliation: Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
authors.forename: Mark
authors.initials: M
authors.lastname: Stonecypher
authors.affiliation: Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
authors.forename: Dale
authors.initials: D
authors.lastname: Frank
authors.affiliation: Department of Infectious Diseases, Philadelphia Veterans Affair Medical Center, Philadelphia, PA; Division of Infectious Diseases, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
authors.forename: Valerianna
authors.initials: V
authors.lastname: Amorosa
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
authors.forename: Jakub
authors.initials: J
authors.lastname: Svoboda
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003952:Diagnostic Imaging; D004317:Doxorubicin / Q000008:administration & dosage; D042241:Early Diagnosis; D020031:Epstein-Barr Virus Infections / Q000150:complications; D005047:Etoposide / Q000008:administration & dosage; D006566:Herpesviridae Infections / Q000150:complications / Q000821:virology; D019288:Herpesvirus 8, Human / Q000302:isolation & purification; D006801:Humans; D051359:Lymphohistiocytosis, Hemophagocytic / Q000188:drug therapy / Q000209:etiology*; D016483:Lymphoma, AIDS-Related / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D054685:Lymphoma, Primary Effusion / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage; D014766:Viremia / Q000150:complications
chemical_list: D000305:Adrenal Cortex Hormones; D019380:Anti-HIV Agents; D058846:Antibodies, Monoclonal, Murine-Derived; D003561:Cytarabine; D000069283:Rituximab; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate
keywords: HHV8; HIV; Human Herpesvirus 8; Non-Hodgkin lymphoma; PEL